SCHEMBL5223591

SCHEMBL5223591

COC(=O)c1cc(N2CCCC2=O)c(OC)c(N2CCCC2=O)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 4/20 0.45
CYP3A4 P08684 2/20 0.45
MAPT P10636 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
HSD17B10 Q99714 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
ATM Q13315 1/20 0.42
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 3/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HPGD P15428 4/20 0.41
CASP6 P55212 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2D6 P10635 2/20 0.41
CYP2C19 P33261 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5219875 0.92 NPC1 (0.47) CYP2C9CYP3A4MAPTSMN1; SMN2HSD17B10
SCHEMBL5222262 0.90 ALDH1A1 (0.50) CYP2C9CYP3A4MAPTSMN1; SMN2HSD17B10
SCHEMBL5218289 0.86 CTSD (0.50) CYP2C9CYP3A4MAPTSMN1; SMN2MEN1
SCHEMBL5219336 0.86 TPMT (0.48) CYP2C9CYP3A4MAPTSMN1; SMN2MEN1
SCHEMBL5219674 0.85 CYP2C9 (0.45) CYP2C9CYP3A4MAPTSMN1; SMN2HSD17B10
SCHEMBL5219617 0.82 HSD17B10 (0.50) CYP2C9CYP3A4MAPTSMN1; SMN2HSD17B10
SCHEMBL15596207 0.81 KDM4E (0.50) CYP2C9CYP3A4MAPTSMN1; SMN2ATM
SCHEMBL5219444 0.80 MEN1 (0.56) CYP2C9CYP3A4MAPTSMN1; SMN2MEN1
SCHEMBL475775 0.80 MEN1 (0.56) CYP2C9CYP3A4MAPTSMN1; SMN2MEN1
SCHEMBL7240806 0.79 KDM4E (0.65) CYP2C9CYP3A4MAPTSMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed
EP-1567488-A1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LIMITED (GB) 2005-08-31 EP disclosed
WO-2004050619-A1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LIMITED (GB) 2004-06-17 WO disclosed